<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The majority of ischemic cerebral insults are caused by <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In animal experiments we have investigated the possibility of reperfusing ischemically damaged brain tissue by thrombolysis of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral emboli</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>1, 3 and 5 hours after <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> due to <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, thrombolytic treatment with urokinase (1000 IU/kg/min) was started </plain></SENT>
<SENT sid="3" pm="."><plain>Thrombolysis, monitored by angiography, was successful in <z:hpo ids='HP_0000001'>all</z:hpo> cases (n = 15) </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases the fall in fibrinogen, alpha 2-antiplasmin and plasminogen reflected systemic fibrinolytic effects </plain></SENT>
<SENT sid="5" pm="."><plain>Anatomo-pathologic investigation of the brains revealed no <z:mp ids='MP_0001916'>intracerebral bleeding</z:mp> complications </plain></SENT>
<SENT sid="6" pm="."><plain>The results of the study suggest a favourable effect of urokinase on <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C1262005" disease_type="Disease or Syndrome" abbrv="">ischemic cerebral infarction</z:e> </plain></SENT>
</text></document>